These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34673013)

  • 1. Cyclin-dependent kinase 1 as a potential target for lycorine against hepatocellular carcinoma.
    Yin S; Yang S; Luo Y; Lu J; Hu G; Wang K; Shao Y; Zhou S; Koo S; Qiu Y; Wang T; Yu H
    Biochem Pharmacol; 2021 Nov; 193():114806. PubMed ID: 34673013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma.
    Zou Y; Ruan S; Jin L; Chen Z; Han H; Zhang Y; Jian Z; Lin Y; Shi N; Jin H
    Med Sci Monit; 2020 Aug; 26():e925289. PubMed ID: 32863381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lycorine inhibited the cell growth of non-small cell lung cancer by modulating the miR-186/CDK1 axis.
    Li L; Zhang Z; Yang Q; Ning M
    Life Sci; 2019 Aug; 231():116528. PubMed ID: 31176784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the molecular targets and mechanisms of compound mylabris capsules for hepatocellular carcinoma treatment through network pharmacology and bioinformatics analysis.
    Wei J; Ma L; Liu W; Wang Y; Shen C; Zhao X; Zhao C
    J Ethnopharmacol; 2021 Aug; 276():114174. PubMed ID: 33932512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the mechanism of quercetin in Sini Decoction Plus Ginseng Soup to inhibit liver cancer and HBV virus replication through CDK1.
    Hao L; Li S; Chen G; Nie A; Zeng L; Xiao Z; Hu X
    Chem Biol Drug Des; 2024 Jun; 103(6):e14567. PubMed ID: 38858165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.
    Lamoral-Theys D; Andolfi A; Van Goietsenoven G; Cimmino A; Le Calvé B; Wauthoz N; Mégalizzi V; Gras T; Bruyère C; Dubois J; Mathieu V; Kornienko A; Kiss R; Evidente A
    J Med Chem; 2009 Oct; 52(20):6244-56. PubMed ID: 19788245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of the immune checkpoint inhibitor CTLA-4 combined with the growth inhibitor lycorine in a mouse model of renal cell carcinoma.
    Li X; Xu P; Wang C; Xu N; Xu A; Xu Y; Sadahira T; Araki M; Wada K; Matsuura E; Watanabe M; Zheng J; Sun P; Huang P; Nasu Y; Liu C
    Oncotarget; 2017 Mar; 8(13):21177-21186. PubMed ID: 28416753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lycorine inhibits glioblastoma multiforme growth through EGFR suppression.
    Shen J; Zhang T; Cheng Z; Zhu N; Wang H; Lin L; Wang Z; Yi H; Hu M
    J Exp Clin Cancer Res; 2018 Jul; 37(1):157. PubMed ID: 30016965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CDK1, CCNB1 and NDC80 are associated with prognosis and progression of hepatitis B virus-associated hepatocellular carcinoma: a bioinformatic analysis].
    Li Y; Wu D; Wei C; Yang X; Zhou S
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1509-1518. PubMed ID: 34755666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-modified cell-penetrating peptide-based self-assembly micelles for co-delivery of narciclasine and siULK1 in hepatocellular carcinoma therapy.
    Wang X; Wu F; Li G; Zhang N; Song X; Zheng Y; Gong C; Han B; He G
    Acta Biomater; 2018 Jul; 74():414-429. PubMed ID: 29787814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lycorine improves peripheral nerve function by promoting Schwann cell autophagy via AMPK pathway activation and MMP9 downregulation in diabetic peripheral neuropathy.
    Yuan Q; Zhang X; Wei W; Zhao J; Wu Y; Zhao S; Zhu L; Wang P; Hao J
    Pharmacol Res; 2022 Jan; 175():105985. PubMed ID: 34863821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lycorine Promotes Autophagy and Apoptosis via TCRP1/Akt/mTOR Axis Inactivation in Human Hepatocellular Carcinoma.
    Yu H; Qiu Y; Pang X; Li J; Wu S; Yin S; Han L; Zhang Y; Jin C; Gao X; Hu W; Wang T
    Mol Cancer Ther; 2017 Dec; 16(12):2711-2723. PubMed ID: 28974556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lycorine: A prospective natural lead for anticancer drug discovery.
    Roy M; Liang L; Xiao X; Feng P; Ye M; Liu J
    Biomed Pharmacother; 2018 Nov; 107():615-624. PubMed ID: 30114645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity and virtual screening by molecular docking of lycorine from Pancratium foetidum Pom (Moroccan endemic Amaryllidaceae).
    Bendaif H; Melhaoui A; Ramdani M; Elmsellem H; Douez C; El Ouadi Y
    Microb Pathog; 2018 Feb; 115():138-145. PubMed ID: 29253598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
    Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
    Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Translation of Cyclin B1 and B2 is Differentially Regulated during Mouse Oocyte Reentry into the Meiotic Cell Cycle.
    Han SJ; Martins JPS; Yang Y; Kang MK; Daldello EM; Conti M
    Sci Rep; 2017 Oct; 7(1):14077. PubMed ID: 29074977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lycorine inhibits cell proliferation and migration by inhibiting ROCK1/cofilin‑induced actin dynamics in HepG2 hepatoblastoma cells.
    Liu W; Zhang Q; Tang Q; Hu C; Huang J; Liu Y; Lu Y; Wang Q; Li G; Zhang R
    Oncol Rep; 2018 Oct; 40(4):2298-2306. PubMed ID: 30066939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lycorine protects cartilage through suppressing the expression of matrix metalloprotenases in rat chondrocytes and in a mouse osteoarthritis model.
    Chen S; Fang XQ; Zhang JF; Ma Y; Tang XZ; Zhou ZJ; Wang JY; Qin A; Fan SW
    Mol Med Rep; 2016 Oct; 14(4):3389-96. PubMed ID: 27509914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lycorine ameliorates bleomycin-induced pulmonary fibrosis via inhibiting NLRP3 inflammasome activation and pyroptosis.
    Liang Q; Cai W; Zhao Y; Xu H; Tang H; Chen D; Qian F; Sun L
    Pharmacol Res; 2020 Aug; 158():104884. PubMed ID: 32428667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mannosylated lipid nano-emulsions loaded with lycorine-oleic acid ionic complex for tumor cell-specific delivery.
    Guo Y; Liu X; Sun X; Zhang Q; Gong T; Zhang Z
    Theranostics; 2012; 2(11):1104-14. PubMed ID: 23227126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.